Evidence map›Paper›PMID 38415717›Full record

ArticleParasite (Paris, France)2024

Efficacy of a combination of esafoxolaner, eprinomectin and praziquantel (NexGard

Angela Di Cesare, Stefania Zanet, Donato Traversa, Mariasole Colombo, Eric Tielemans, Frederic Beugnet, Ezio Ferroglio

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Parasite (Paris, France), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Nematicidal Effects and Cytotoxicity of Levamisole onAnimals : an open access journal from MDPI · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Angela Di CesareDepartment of Veterinary Medicine, University of Teramo, Località Piano d'Accio, 64100 Teramo, Italy.
Stefania ZanetDepartment of Veterinary Sciences, University of Turin, Largo Paolo Braccini 2, 10095 Grugliasco, Turin, Italy.
Donato TraversaDepartment of Veterinary Medicine, University of Teramo, Località Piano d'Accio, 64100 Teramo, Italy.
Mariasole ColomboDepartment of Veterinary Medicine, University of Teramo, Località Piano d'Accio, 64100 Teramo, Italy.
Eric TielemansBoehringer Ingelheim Animal Health, 29 Avenue Tony Garnier, 69007 Lyon, France.
Frederic BeugnetBoehringer Ingelheim Animal Health, 29 Avenue Tony Garnier, 69007 Lyon, France.
Ezio FerroglioDepartment of Veterinary Sciences, University of Turin, Largo Paolo Braccini 2, 10095 Grugliasco, Turin, Italy.
University of Teramo · ITUniversity of Turin · ITBoehringer Ingelheim (France) · FRDépartement Santé Animale · FR

Funding

Boehringer Ingelheim France 2021-1544
6 · The paper itself

Abstract

This clinical study assessed the efficacy of a topical combination of esafoxolaner, eprinomectin and praziquantel (NexGard

Indexed as

IsoxazolesNaphthalenesPraziquantelThelazioideaAnimalsCatsHumansIvermectinafoxolanereprinomectinIsoxazolesIvermectinNaphthalenesPraziquantelCatEprinomectinNexGard® ComboThelazia callipaeda

Identifiers

PMID38415717
PMCPMC10901074
OpenAlexW4392249727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.